Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
J-Y Reginster, S Adami, P Lakatos, M Greenwald, J J Stepan, S L Silverman, C Christiansen, L Rowell, N Mairon, B Bonvoisin, M K Drezner, R Emkey, D Felsenberg, C Cooper, P D Delmas, P D Miller
Annals of the Rheumatic Diseases May 2006, 65 (5) 654-661; DOI: 10.1136/ard.2005.044958